CD8A and large cell neuroendocrine carcinoma: investigated PD-L1 (scored positive if tumors showed ≥1% membranous staining) and CD8 expression (scored for intra-tumor T-cells and stromal cells) in advanced LCNEC, showing PD-L1 positivity in 16% of tumor samples.